nodes	percent_of_prediction	percent_of_DWPC	metapath
Ezogabine—KCNQ4—epilepsy syndrome	0.166	0.397	CbGaD
Ezogabine—KCNQ2—epilepsy syndrome	0.126	0.301	CbGaD
Ezogabine—KCNQ3—epilepsy syndrome	0.126	0.301	CbGaD
Ezogabine—NAT2—Clonazepam—epilepsy syndrome	0.0921	0.259	CbGbCtD
Ezogabine—UGT1A4—Lamotrigine—epilepsy syndrome	0.0615	0.173	CbGbCtD
Ezogabine—UGT1A4—Midazolam—epilepsy syndrome	0.0417	0.117	CbGbCtD
Ezogabine—UGT1A3—Lamotrigine—epilepsy syndrome	0.0324	0.0911	CbGbCtD
Ezogabine—UGT1A4—Valproic Acid—epilepsy syndrome	0.0316	0.0888	CbGbCtD
Ezogabine—UGT1A9—Propofol—epilepsy syndrome	0.0178	0.0501	CbGbCtD
Ezogabine—UGT1A3—Valproic Acid—epilepsy syndrome	0.0167	0.0469	CbGbCtD
Ezogabine—UGT1A1—Propofol—epilepsy syndrome	0.0146	0.041	CbGbCtD
Ezogabine—UGT1A9—Valproic Acid—epilepsy syndrome	0.0127	0.0358	CbGbCtD
Ezogabine—CYP2A6—Amobarbital—epilepsy syndrome	0.0116	0.0327	CbGbCtD
Ezogabine—CYP2A6—Propofol—epilepsy syndrome	0.00867	0.0244	CbGbCtD
Ezogabine—CYP2A6—Phenobarbital—epilepsy syndrome	0.00829	0.0233	CbGbCtD
Ezogabine—CYP2A6—Valproic Acid—epilepsy syndrome	0.00619	0.0174	CbGbCtD
Ezogabine—KCNQ4—ear—epilepsy syndrome	0.00474	0.215	CbGeAlD
Ezogabine—Flupirtine—ADRA2A—epilepsy syndrome	0.00194	1	CrCbGaD
Ezogabine—KCNQ5—forebrain—epilepsy syndrome	0.0012	0.0546	CbGeAlD
Ezogabine—KCNQ3—forebrain—epilepsy syndrome	0.000966	0.0438	CbGeAlD
Ezogabine—KCNQ2—brainstem—epilepsy syndrome	0.000921	0.0418	CbGeAlD
Ezogabine—KCNQ2—forebrain—epilepsy syndrome	0.000889	0.0403	CbGeAlD
Ezogabine—KCNQ3—telencephalon—epilepsy syndrome	0.000888	0.0403	CbGeAlD
Ezogabine—KCNQ2—telencephalon—epilepsy syndrome	0.000818	0.0371	CbGeAlD
Ezogabine—KCNQ5—midbrain—epilepsy syndrome	0.000795	0.0361	CbGeAlD
Ezogabine—KCNQ4—head—epilepsy syndrome	0.000709	0.0321	CbGeAlD
Ezogabine—KCNQ3—medulla oblongata—epilepsy syndrome	0.000698	0.0317	CbGeAlD
Ezogabine—KCNQ5—head—epilepsy syndrome	0.000689	0.0313	CbGeAlD
Ezogabine—KCNQ5—nervous system—epilepsy syndrome	0.000654	0.0296	CbGeAlD
Ezogabine—KCNQ3—midbrain—epilepsy syndrome	0.000638	0.0289	CbGeAlD
Ezogabine—KCNQ4—cerebellum—epilepsy syndrome	0.000632	0.0287	CbGeAlD
Ezogabine—KCNQ5—central nervous system—epilepsy syndrome	0.000629	0.0285	CbGeAlD
Ezogabine—KCNQ3—head—epilepsy syndrome	0.000553	0.0251	CbGeAlD
Ezogabine—KCNQ3—nervous system—epilepsy syndrome	0.000524	0.0238	CbGeAlD
Ezogabine—KCNQ4—brain—epilepsy syndrome	0.000513	0.0233	CbGeAlD
Ezogabine—KCNQ2—head—epilepsy syndrome	0.000509	0.0231	CbGeAlD
Ezogabine—KCNQ3—central nervous system—epilepsy syndrome	0.000505	0.0229	CbGeAlD
Ezogabine—KCNQ5—brain—epilepsy syndrome	0.0005	0.0227	CbGeAlD
Ezogabine—KCNQ3—cerebellum—epilepsy syndrome	0.000494	0.0224	CbGeAlD
Ezogabine—KCNQ2—nervous system—epilepsy syndrome	0.000483	0.0219	CbGeAlD
Ezogabine—KCNQ2—central nervous system—epilepsy syndrome	0.000465	0.0211	CbGeAlD
Ezogabine—KCNQ2—cerebellum—epilepsy syndrome	0.000454	0.0206	CbGeAlD
Ezogabine—KCNQ3—brain—epilepsy syndrome	0.000401	0.0182	CbGeAlD
Ezogabine—KCNQ2—brain—epilepsy syndrome	0.000369	0.0167	CbGeAlD
Ezogabine—CYP2A6—cerebellum—epilepsy syndrome	0.000226	0.0102	CbGeAlD
Ezogabine—CYP2A6—brain—epilepsy syndrome	0.000183	0.00831	CbGeAlD
Ezogabine—Dyspepsia—Clonazepam—epilepsy syndrome	4.55e-05	0.000396	CcSEcCtD
Ezogabine—Somnolence—Oxcarbazepine—epilepsy syndrome	4.54e-05	0.000395	CcSEcCtD
Ezogabine—Nausea—Clobazam—epilepsy syndrome	4.54e-05	0.000395	CcSEcCtD
Ezogabine—Asthenia—Propofol—epilepsy syndrome	4.54e-05	0.000395	CcSEcCtD
Ezogabine—Dyspepsia—Phenytoin—epilepsy syndrome	4.52e-05	0.000393	CcSEcCtD
Ezogabine—Feeling abnormal—Felbamate—epilepsy syndrome	4.51e-05	0.000393	CcSEcCtD
Ezogabine—Dizziness—Acetazolamide—epilepsy syndrome	4.5e-05	0.000392	CcSEcCtD
Ezogabine—Dyspepsia—Oxcarbazepine—epilepsy syndrome	4.49e-05	0.000391	CcSEcCtD
Ezogabine—Eye disorder—Pregabalin—epilepsy syndrome	4.47e-05	0.00039	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Clonazepam—epilepsy syndrome	4.46e-05	0.000388	CcSEcCtD
Ezogabine—Fatigue—Clonazepam—epilepsy syndrome	4.45e-05	0.000388	CcSEcCtD
Ezogabine—Asthenia—Midazolam—epilepsy syndrome	4.44e-05	0.000387	CcSEcCtD
Ezogabine—Muscle spasms—Valproic Acid—epilepsy syndrome	4.43e-05	0.000386	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Phenytoin—epilepsy syndrome	4.43e-05	0.000386	CcSEcCtD
Ezogabine—Fatigue—Phenytoin—epilepsy syndrome	4.42e-05	0.000385	CcSEcCtD
Ezogabine—Constipation—Clonazepam—epilepsy syndrome	4.42e-05	0.000385	CcSEcCtD
Ezogabine—Feeling abnormal—Zonisamide—epilepsy syndrome	4.42e-05	0.000385	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Oxcarbazepine—epilepsy syndrome	4.41e-05	0.000384	CcSEcCtD
Ezogabine—Fatigue—Oxcarbazepine—epilepsy syndrome	4.4e-05	0.000383	CcSEcCtD
Ezogabine—Paraesthesia—Carbamazepine—epilepsy syndrome	4.4e-05	0.000383	CcSEcCtD
Ezogabine—Constipation—Phenytoin—epilepsy syndrome	4.39e-05	0.000382	CcSEcCtD
Ezogabine—Asthenia—Levetiracetam—epilepsy syndrome	4.38e-05	0.000382	CcSEcCtD
Ezogabine—Hallucination—Gabapentin—epilepsy syndrome	4.37e-05	0.00038	CcSEcCtD
Ezogabine—Dyspnoea—Carbamazepine—epilepsy syndrome	4.37e-05	0.00038	CcSEcCtD
Ezogabine—Constipation—Oxcarbazepine—epilepsy syndrome	4.36e-05	0.00038	CcSEcCtD
Ezogabine—Somnolence—Carbamazepine—epilepsy syndrome	4.35e-05	0.000379	CcSEcCtD
Ezogabine—Vision blurred—Valproic Acid—epilepsy syndrome	4.34e-05	0.000378	CcSEcCtD
Ezogabine—Urinary tract disorder—Gabapentin—epilepsy syndrome	4.33e-05	0.000377	CcSEcCtD
Ezogabine—Oedema peripheral—Gabapentin—epilepsy syndrome	4.32e-05	0.000377	CcSEcCtD
Ezogabine—Tremor—Valproic Acid—epilepsy syndrome	4.32e-05	0.000376	CcSEcCtD
Ezogabine—Neutropenia—Topiramate—epilepsy syndrome	4.31e-05	0.000376	CcSEcCtD
Ezogabine—Dysuria—Topiramate—epilepsy syndrome	4.31e-05	0.000376	CcSEcCtD
Ezogabine—Dyspepsia—Carbamazepine—epilepsy syndrome	4.31e-05	0.000375	CcSEcCtD
Ezogabine—Urethral disorder—Gabapentin—epilepsy syndrome	4.3e-05	0.000375	CcSEcCtD
Ezogabine—Ill-defined disorder—Valproic Acid—epilepsy syndrome	4.28e-05	0.000372	CcSEcCtD
Ezogabine—Feeling abnormal—Clonazepam—epilepsy syndrome	4.26e-05	0.000371	CcSEcCtD
Ezogabine—Paraesthesia—Lamotrigine—epilepsy syndrome	4.25e-05	0.00037	CcSEcCtD
Ezogabine—Asthenia—Fosphenytoin—epilepsy syndrome	4.23e-05	0.000368	CcSEcCtD
Ezogabine—Visual impairment—Gabapentin—epilepsy syndrome	4.23e-05	0.000368	CcSEcCtD
Ezogabine—Alopecia—Pregabalin—epilepsy syndrome	4.23e-05	0.000368	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Carbamazepine—epilepsy syndrome	4.23e-05	0.000368	CcSEcCtD
Ezogabine—Feeling abnormal—Phenytoin—epilepsy syndrome	4.23e-05	0.000368	CcSEcCtD
Ezogabine—Fatigue—Carbamazepine—epilepsy syndrome	4.22e-05	0.000368	CcSEcCtD
Ezogabine—Dyspnoea—Lamotrigine—epilepsy syndrome	4.22e-05	0.000368	CcSEcCtD
Ezogabine—Somnolence—Lamotrigine—epilepsy syndrome	4.21e-05	0.000366	CcSEcCtD
Ezogabine—Feeling abnormal—Oxcarbazepine—epilepsy syndrome	4.21e-05	0.000366	CcSEcCtD
Ezogabine—Weight increased—Topiramate—epilepsy syndrome	4.2e-05	0.000366	CcSEcCtD
Ezogabine—Mental disorder—Pregabalin—epilepsy syndrome	4.19e-05	0.000365	CcSEcCtD
Ezogabine—Constipation—Carbamazepine—epilepsy syndrome	4.19e-05	0.000365	CcSEcCtD
Ezogabine—Dizziness—Propofol—epilepsy syndrome	4.18e-05	0.000364	CcSEcCtD
Ezogabine—Dyspepsia—Lamotrigine—epilepsy syndrome	4.17e-05	0.000363	CcSEcCtD
Ezogabine—Malnutrition—Pregabalin—epilepsy syndrome	4.17e-05	0.000363	CcSEcCtD
Ezogabine—Malaise—Valproic Acid—epilepsy syndrome	4.16e-05	0.000362	CcSEcCtD
Ezogabine—Vertigo—Valproic Acid—epilepsy syndrome	4.14e-05	0.000361	CcSEcCtD
Ezogabine—Leukopenia—Valproic Acid—epilepsy syndrome	4.13e-05	0.000359	CcSEcCtD
Ezogabine—Asthenia—Vigabatrin—epilepsy syndrome	4.12e-05	0.000359	CcSEcCtD
Ezogabine—Infestation NOS—Topiramate—epilepsy syndrome	4.11e-05	0.000358	CcSEcCtD
Ezogabine—Infestation—Topiramate—epilepsy syndrome	4.11e-05	0.000358	CcSEcCtD
Ezogabine—Eye disorder—Gabapentin—epilepsy syndrome	4.1e-05	0.000357	CcSEcCtD
Ezogabine—Dizziness—Midazolam—epilepsy syndrome	4.09e-05	0.000356	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Lamotrigine—epilepsy syndrome	4.09e-05	0.000356	CcSEcCtD
Ezogabine—Fatigue—Lamotrigine—epilepsy syndrome	4.08e-05	0.000355	CcSEcCtD
Ezogabine—Asthenia—Diazepam—epilepsy syndrome	4.06e-05	0.000354	CcSEcCtD
Ezogabine—Constipation—Lamotrigine—epilepsy syndrome	4.05e-05	0.000353	CcSEcCtD
Ezogabine—Nausea—Acetazolamide—epilepsy syndrome	4.04e-05	0.000352	CcSEcCtD
Ezogabine—Dizziness—Levetiracetam—epilepsy syndrome	4.04e-05	0.000352	CcSEcCtD
Ezogabine—Feeling abnormal—Carbamazepine—epilepsy syndrome	4.04e-05	0.000351	CcSEcCtD
Ezogabine—Muscle spasms—Pregabalin—epilepsy syndrome	4.01e-05	0.000349	CcSEcCtD
Ezogabine—Rash—Propofol—epilepsy syndrome	3.99e-05	0.000347	CcSEcCtD
Ezogabine—Dermatitis—Propofol—epilepsy syndrome	3.98e-05	0.000347	CcSEcCtD
Ezogabine—Asthenia—Felbamate—epilepsy syndrome	3.93e-05	0.000342	CcSEcCtD
Ezogabine—Vision blurred—Pregabalin—epilepsy syndrome	3.93e-05	0.000342	CcSEcCtD
Ezogabine—Haematuria—Topiramate—epilepsy syndrome	3.92e-05	0.000342	CcSEcCtD
Ezogabine—Anxiety—Valproic Acid—epilepsy syndrome	3.91e-05	0.000341	CcSEcCtD
Ezogabine—Tremor—Pregabalin—epilepsy syndrome	3.9e-05	0.00034	CcSEcCtD
Ezogabine—Feeling abnormal—Lamotrigine—epilepsy syndrome	3.9e-05	0.00034	CcSEcCtD
Ezogabine—Rash—Midazolam—epilepsy syndrome	3.9e-05	0.00034	CcSEcCtD
Ezogabine—Dizziness—Fosphenytoin—epilepsy syndrome	3.9e-05	0.00034	CcSEcCtD
Ezogabine—Dermatitis—Midazolam—epilepsy syndrome	3.9e-05	0.000339	CcSEcCtD
Ezogabine—Alopecia—Gabapentin—epilepsy syndrome	3.88e-05	0.000338	CcSEcCtD
Ezogabine—Discomfort—Valproic Acid—epilepsy syndrome	3.88e-05	0.000338	CcSEcCtD
Ezogabine—Ill-defined disorder—Pregabalin—epilepsy syndrome	3.87e-05	0.000337	CcSEcCtD
Ezogabine—Rash—Levetiracetam—epilepsy syndrome	3.85e-05	0.000335	CcSEcCtD
Ezogabine—Dermatitis—Levetiracetam—epilepsy syndrome	3.85e-05	0.000335	CcSEcCtD
Ezogabine—Asthenia—Zonisamide—epilepsy syndrome	3.85e-05	0.000335	CcSEcCtD
Ezogabine—Mental disorder—Gabapentin—epilepsy syndrome	3.84e-05	0.000335	CcSEcCtD
Ezogabine—Dry mouth—Valproic Acid—epilepsy syndrome	3.84e-05	0.000334	CcSEcCtD
Ezogabine—Malnutrition—Gabapentin—epilepsy syndrome	3.82e-05	0.000333	CcSEcCtD
Ezogabine—Dizziness—Vigabatrin—epilepsy syndrome	3.8e-05	0.000331	CcSEcCtD
Ezogabine—Confusional state—Valproic Acid—epilepsy syndrome	3.79e-05	0.00033	CcSEcCtD
Ezogabine—Malaise—Pregabalin—epilepsy syndrome	3.76e-05	0.000327	CcSEcCtD
Ezogabine—Nausea—Propofol—epilepsy syndrome	3.76e-05	0.000327	CcSEcCtD
Ezogabine—Vertigo—Pregabalin—epilepsy syndrome	3.74e-05	0.000326	CcSEcCtD
Ezogabine—Dizziness—Diazepam—epilepsy syndrome	3.74e-05	0.000326	CcSEcCtD
Ezogabine—Infection—Valproic Acid—epilepsy syndrome	3.74e-05	0.000325	CcSEcCtD
Ezogabine—Syncope—Pregabalin—epilepsy syndrome	3.74e-05	0.000325	CcSEcCtD
Ezogabine—Leukopenia—Pregabalin—epilepsy syndrome	3.73e-05	0.000325	CcSEcCtD
Ezogabine—Rash—Fosphenytoin—epilepsy syndrome	3.72e-05	0.000324	CcSEcCtD
Ezogabine—Dermatitis—Fosphenytoin—epilepsy syndrome	3.71e-05	0.000323	CcSEcCtD
Ezogabine—Asthenia—Clonazepam—epilepsy syndrome	3.71e-05	0.000323	CcSEcCtD
Ezogabine—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.69e-05	0.000321	CcSEcCtD
Ezogabine—Thrombocytopenia—Valproic Acid—epilepsy syndrome	3.68e-05	0.000321	CcSEcCtD
Ezogabine—Asthenia—Phenytoin—epilepsy syndrome	3.68e-05	0.000321	CcSEcCtD
Ezogabine—Nausea—Midazolam—epilepsy syndrome	3.67e-05	0.00032	CcSEcCtD
Ezogabine—Hallucination—Topiramate—epilepsy syndrome	3.67e-05	0.00032	CcSEcCtD
Ezogabine—Muscle spasms—Gabapentin—epilepsy syndrome	3.67e-05	0.00032	CcSEcCtD
Ezogabine—Loss of consciousness—Pregabalin—epilepsy syndrome	3.66e-05	0.000319	CcSEcCtD
Ezogabine—Asthenia—Oxcarbazepine—epilepsy syndrome	3.66e-05	0.000319	CcSEcCtD
Ezogabine—Urinary tract disorder—Topiramate—epilepsy syndrome	3.65e-05	0.000318	CcSEcCtD
Ezogabine—Oedema peripheral—Topiramate—epilepsy syndrome	3.64e-05	0.000317	CcSEcCtD
Ezogabine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	3.64e-05	0.000317	CcSEcCtD
Ezogabine—Nausea—Levetiracetam—epilepsy syndrome	3.63e-05	0.000316	CcSEcCtD
Ezogabine—Rash—Vigabatrin—epilepsy syndrome	3.62e-05	0.000316	CcSEcCtD
Ezogabine—Dizziness—Felbamate—epilepsy syndrome	3.62e-05	0.000315	CcSEcCtD
Ezogabine—Dermatitis—Vigabatrin—epilepsy syndrome	3.62e-05	0.000315	CcSEcCtD
Ezogabine—Urethral disorder—Topiramate—epilepsy syndrome	3.62e-05	0.000315	CcSEcCtD
Ezogabine—Vision blurred—Gabapentin—epilepsy syndrome	3.6e-05	0.000314	CcSEcCtD
Ezogabine—Tremor—Gabapentin—epilepsy syndrome	3.58e-05	0.000312	CcSEcCtD
Ezogabine—Rash—Diazepam—epilepsy syndrome	3.57e-05	0.000311	CcSEcCtD
Ezogabine—Dermatitis—Diazepam—epilepsy syndrome	3.56e-05	0.00031	CcSEcCtD
Ezogabine—Visual impairment—Topiramate—epilepsy syndrome	3.56e-05	0.00031	CcSEcCtD
Ezogabine—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.54e-05	0.000309	CcSEcCtD
Ezogabine—Dizziness—Zonisamide—epilepsy syndrome	3.54e-05	0.000309	CcSEcCtD
Ezogabine—Anxiety—Pregabalin—epilepsy syndrome	3.53e-05	0.000308	CcSEcCtD
Ezogabine—Asthenia—Carbamazepine—epilepsy syndrome	3.51e-05	0.000306	CcSEcCtD
Ezogabine—Discomfort—Pregabalin—epilepsy syndrome	3.5e-05	0.000305	CcSEcCtD
Ezogabine—Nausea—Fosphenytoin—epilepsy syndrome	3.5e-05	0.000305	CcSEcCtD
Ezogabine—Dry mouth—Pregabalin—epilepsy syndrome	3.47e-05	0.000302	CcSEcCtD
Ezogabine—Rash—Felbamate—epilepsy syndrome	3.45e-05	0.000301	CcSEcCtD
Ezogabine—Eye disorder—Topiramate—epilepsy syndrome	3.45e-05	0.000301	CcSEcCtD
Ezogabine—Dermatitis—Felbamate—epilepsy syndrome	3.45e-05	0.0003	CcSEcCtD
Ezogabine—Malaise—Gabapentin—epilepsy syndrome	3.45e-05	0.0003	CcSEcCtD
Ezogabine—Vertigo—Gabapentin—epilepsy syndrome	3.43e-05	0.000299	CcSEcCtD
Ezogabine—Confusional state—Pregabalin—epilepsy syndrome	3.43e-05	0.000299	CcSEcCtD
Ezogabine—Syncope—Gabapentin—epilepsy syndrome	3.43e-05	0.000298	CcSEcCtD
Ezogabine—Leukopenia—Gabapentin—epilepsy syndrome	3.42e-05	0.000298	CcSEcCtD
Ezogabine—Dizziness—Clonazepam—epilepsy syndrome	3.42e-05	0.000297	CcSEcCtD
Ezogabine—Nausea—Vigabatrin—epilepsy syndrome	3.41e-05	0.000297	CcSEcCtD
Ezogabine—Asthenia—Lamotrigine—epilepsy syndrome	3.4e-05	0.000296	CcSEcCtD
Ezogabine—Dizziness—Phenytoin—epilepsy syndrome	3.39e-05	0.000295	CcSEcCtD
Ezogabine—Rash—Zonisamide—epilepsy syndrome	3.38e-05	0.000294	CcSEcCtD
Ezogabine—Infection—Pregabalin—epilepsy syndrome	3.38e-05	0.000294	CcSEcCtD
Ezogabine—Paraesthesia—Valproic Acid—epilepsy syndrome	3.38e-05	0.000294	CcSEcCtD
Ezogabine—Dermatitis—Zonisamide—epilepsy syndrome	3.38e-05	0.000294	CcSEcCtD
Ezogabine—Dizziness—Oxcarbazepine—epilepsy syndrome	3.37e-05	0.000294	CcSEcCtD
Ezogabine—Nausea—Diazepam—epilepsy syndrome	3.36e-05	0.000293	CcSEcCtD
Ezogabine—Loss of consciousness—Gabapentin—epilepsy syndrome	3.36e-05	0.000292	CcSEcCtD
Ezogabine—Dyspnoea—Valproic Acid—epilepsy syndrome	3.35e-05	0.000292	CcSEcCtD
Ezogabine—Shock—Pregabalin—epilepsy syndrome	3.35e-05	0.000291	CcSEcCtD
Ezogabine—Somnolence—Valproic Acid—epilepsy syndrome	3.34e-05	0.000291	CcSEcCtD
Ezogabine—Nervous system disorder—Pregabalin—epilepsy syndrome	3.33e-05	0.00029	CcSEcCtD
Ezogabine—Thrombocytopenia—Pregabalin—epilepsy syndrome	3.33e-05	0.00029	CcSEcCtD
Ezogabine—Dyspepsia—Valproic Acid—epilepsy syndrome	3.31e-05	0.000288	CcSEcCtD
Ezogabine—Hyperhidrosis—Pregabalin—epilepsy syndrome	3.29e-05	0.000286	CcSEcCtD
Ezogabine—Alopecia—Topiramate—epilepsy syndrome	3.26e-05	0.000284	CcSEcCtD
Ezogabine—Rash—Clonazepam—epilepsy syndrome	3.26e-05	0.000284	CcSEcCtD
Ezogabine—Dermatitis—Clonazepam—epilepsy syndrome	3.25e-05	0.000283	CcSEcCtD
Ezogabine—Nausea—Felbamate—epilepsy syndrome	3.25e-05	0.000283	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.25e-05	0.000283	CcSEcCtD
Ezogabine—Fatigue—Valproic Acid—epilepsy syndrome	3.24e-05	0.000282	CcSEcCtD
Ezogabine—Anxiety—Gabapentin—epilepsy syndrome	3.24e-05	0.000282	CcSEcCtD
Ezogabine—Dizziness—Carbamazepine—epilepsy syndrome	3.24e-05	0.000282	CcSEcCtD
Ezogabine—Rash—Phenytoin—epilepsy syndrome	3.23e-05	0.000282	CcSEcCtD
Ezogabine—Mental disorder—Topiramate—epilepsy syndrome	3.23e-05	0.000282	CcSEcCtD
Ezogabine—Dermatitis—Phenytoin—epilepsy syndrome	3.23e-05	0.000281	CcSEcCtD
Ezogabine—Rash—Oxcarbazepine—epilepsy syndrome	3.22e-05	0.00028	CcSEcCtD
Ezogabine—Constipation—Valproic Acid—epilepsy syndrome	3.22e-05	0.00028	CcSEcCtD
Ezogabine—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.21e-05	0.00028	CcSEcCtD
Ezogabine—Malnutrition—Topiramate—epilepsy syndrome	3.21e-05	0.00028	CcSEcCtD
Ezogabine—Discomfort—Gabapentin—epilepsy syndrome	3.21e-05	0.00028	CcSEcCtD
Ezogabine—Nausea—Zonisamide—epilepsy syndrome	3.18e-05	0.000277	CcSEcCtD
Ezogabine—Dry mouth—Gabapentin—epilepsy syndrome	3.18e-05	0.000277	CcSEcCtD
Ezogabine—Confusional state—Gabapentin—epilepsy syndrome	3.14e-05	0.000274	CcSEcCtD
Ezogabine—Dizziness—Lamotrigine—epilepsy syndrome	3.13e-05	0.000273	CcSEcCtD
Ezogabine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.1e-05	0.00027	CcSEcCtD
Ezogabine—Infection—Gabapentin—epilepsy syndrome	3.1e-05	0.00027	CcSEcCtD
Ezogabine—Muscle spasms—Topiramate—epilepsy syndrome	3.09e-05	0.000269	CcSEcCtD
Ezogabine—Rash—Carbamazepine—epilepsy syndrome	3.09e-05	0.000269	CcSEcCtD
Ezogabine—Dermatitis—Carbamazepine—epilepsy syndrome	3.09e-05	0.000269	CcSEcCtD
Ezogabine—Nausea—Clonazepam—epilepsy syndrome	3.07e-05	0.000267	CcSEcCtD
Ezogabine—Shock—Gabapentin—epilepsy syndrome	3.07e-05	0.000267	CcSEcCtD
Ezogabine—Nervous system disorder—Gabapentin—epilepsy syndrome	3.06e-05	0.000266	CcSEcCtD
Ezogabine—Paraesthesia—Pregabalin—epilepsy syndrome	3.05e-05	0.000266	CcSEcCtD
Ezogabine—Thrombocytopenia—Gabapentin—epilepsy syndrome	3.05e-05	0.000266	CcSEcCtD
Ezogabine—Nausea—Phenytoin—epilepsy syndrome	3.05e-05	0.000265	CcSEcCtD
Ezogabine—Dyspnoea—Pregabalin—epilepsy syndrome	3.03e-05	0.000264	CcSEcCtD
Ezogabine—Nausea—Oxcarbazepine—epilepsy syndrome	3.03e-05	0.000264	CcSEcCtD
Ezogabine—Vision blurred—Topiramate—epilepsy syndrome	3.03e-05	0.000264	CcSEcCtD
Ezogabine—Somnolence—Pregabalin—epilepsy syndrome	3.02e-05	0.000263	CcSEcCtD
Ezogabine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.01e-05	0.000263	CcSEcCtD
Ezogabine—Tremor—Topiramate—epilepsy syndrome	3.01e-05	0.000262	CcSEcCtD
Ezogabine—Rash—Lamotrigine—epilepsy syndrome	2.98e-05	0.00026	CcSEcCtD
Ezogabine—Ill-defined disorder—Topiramate—epilepsy syndrome	2.98e-05	0.00026	CcSEcCtD
Ezogabine—Dermatitis—Lamotrigine—epilepsy syndrome	2.98e-05	0.00026	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.94e-05	0.000256	CcSEcCtD
Ezogabine—Fatigue—Pregabalin—epilepsy syndrome	2.93e-05	0.000255	CcSEcCtD
Ezogabine—Nausea—Carbamazepine—epilepsy syndrome	2.91e-05	0.000253	CcSEcCtD
Ezogabine—Constipation—Pregabalin—epilepsy syndrome	2.91e-05	0.000253	CcSEcCtD
Ezogabine—Malaise—Topiramate—epilepsy syndrome	2.9e-05	0.000252	CcSEcCtD
Ezogabine—Vertigo—Topiramate—epilepsy syndrome	2.89e-05	0.000252	CcSEcCtD
Ezogabine—Syncope—Topiramate—epilepsy syndrome	2.88e-05	0.000251	CcSEcCtD
Ezogabine—Leukopenia—Topiramate—epilepsy syndrome	2.88e-05	0.000251	CcSEcCtD
Ezogabine—Loss of consciousness—Topiramate—epilepsy syndrome	2.83e-05	0.000246	CcSEcCtD
Ezogabine—Nausea—Lamotrigine—epilepsy syndrome	2.81e-05	0.000245	CcSEcCtD
Ezogabine—Feeling abnormal—Pregabalin—epilepsy syndrome	2.8e-05	0.000244	CcSEcCtD
Ezogabine—Paraesthesia—Gabapentin—epilepsy syndrome	2.8e-05	0.000244	CcSEcCtD
Ezogabine—Dyspnoea—Gabapentin—epilepsy syndrome	2.78e-05	0.000242	CcSEcCtD
Ezogabine—Somnolence—Gabapentin—epilepsy syndrome	2.77e-05	0.000241	CcSEcCtD
Ezogabine—Dyspepsia—Gabapentin—epilepsy syndrome	2.74e-05	0.000239	CcSEcCtD
Ezogabine—Anxiety—Topiramate—epilepsy syndrome	2.73e-05	0.000238	CcSEcCtD
Ezogabine—Discomfort—Topiramate—epilepsy syndrome	2.7e-05	0.000235	CcSEcCtD
Ezogabine—Asthenia—Valproic Acid—epilepsy syndrome	2.7e-05	0.000235	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.69e-05	0.000234	CcSEcCtD
Ezogabine—Fatigue—Gabapentin—epilepsy syndrome	2.69e-05	0.000234	CcSEcCtD
Ezogabine—Dry mouth—Topiramate—epilepsy syndrome	2.68e-05	0.000233	CcSEcCtD
Ezogabine—Constipation—Gabapentin—epilepsy syndrome	2.67e-05	0.000232	CcSEcCtD
Ezogabine—Confusional state—Topiramate—epilepsy syndrome	2.65e-05	0.00023	CcSEcCtD
Ezogabine—Infection—Topiramate—epilepsy syndrome	2.61e-05	0.000227	CcSEcCtD
Ezogabine—Shock—Topiramate—epilepsy syndrome	2.58e-05	0.000225	CcSEcCtD
Ezogabine—Nervous system disorder—Topiramate—epilepsy syndrome	2.57e-05	0.000224	CcSEcCtD
Ezogabine—Feeling abnormal—Gabapentin—epilepsy syndrome	2.57e-05	0.000224	CcSEcCtD
Ezogabine—Thrombocytopenia—Topiramate—epilepsy syndrome	2.57e-05	0.000224	CcSEcCtD
Ezogabine—Hyperhidrosis—Topiramate—epilepsy syndrome	2.54e-05	0.000221	CcSEcCtD
Ezogabine—Dizziness—Valproic Acid—epilepsy syndrome	2.49e-05	0.000217	CcSEcCtD
Ezogabine—Asthenia—Pregabalin—epilepsy syndrome	2.44e-05	0.000212	CcSEcCtD
Ezogabine—Rash—Valproic Acid—epilepsy syndrome	2.37e-05	0.000207	CcSEcCtD
Ezogabine—Dermatitis—Valproic Acid—epilepsy syndrome	2.37e-05	0.000206	CcSEcCtD
Ezogabine—Paraesthesia—Topiramate—epilepsy syndrome	2.36e-05	0.000205	CcSEcCtD
Ezogabine—Dyspnoea—Topiramate—epilepsy syndrome	2.34e-05	0.000204	CcSEcCtD
Ezogabine—Somnolence—Topiramate—epilepsy syndrome	2.33e-05	0.000203	CcSEcCtD
Ezogabine—Dyspepsia—Topiramate—epilepsy syndrome	2.31e-05	0.000201	CcSEcCtD
Ezogabine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.26e-05	0.000197	CcSEcCtD
Ezogabine—Fatigue—Topiramate—epilepsy syndrome	2.26e-05	0.000197	CcSEcCtD
Ezogabine—Dizziness—Pregabalin—epilepsy syndrome	2.25e-05	0.000196	CcSEcCtD
Ezogabine—Constipation—Topiramate—epilepsy syndrome	2.24e-05	0.000195	CcSEcCtD
Ezogabine—Asthenia—Gabapentin—epilepsy syndrome	2.24e-05	0.000195	CcSEcCtD
Ezogabine—Nausea—Valproic Acid—epilepsy syndrome	2.23e-05	0.000195	CcSEcCtD
Ezogabine—Feeling abnormal—Topiramate—epilepsy syndrome	2.16e-05	0.000188	CcSEcCtD
Ezogabine—Rash—Pregabalin—epilepsy syndrome	2.14e-05	0.000187	CcSEcCtD
Ezogabine—Dermatitis—Pregabalin—epilepsy syndrome	2.14e-05	0.000187	CcSEcCtD
Ezogabine—Dizziness—Gabapentin—epilepsy syndrome	2.06e-05	0.00018	CcSEcCtD
Ezogabine—Nausea—Pregabalin—epilepsy syndrome	2.02e-05	0.000176	CcSEcCtD
Ezogabine—Rash—Gabapentin—epilepsy syndrome	1.97e-05	0.000171	CcSEcCtD
Ezogabine—Dermatitis—Gabapentin—epilepsy syndrome	1.96e-05	0.000171	CcSEcCtD
Ezogabine—Asthenia—Topiramate—epilepsy syndrome	1.88e-05	0.000164	CcSEcCtD
Ezogabine—Nausea—Gabapentin—epilepsy syndrome	1.85e-05	0.000161	CcSEcCtD
Ezogabine—Dizziness—Topiramate—epilepsy syndrome	1.73e-05	0.000151	CcSEcCtD
Ezogabine—Rash—Topiramate—epilepsy syndrome	1.65e-05	0.000144	CcSEcCtD
Ezogabine—Dermatitis—Topiramate—epilepsy syndrome	1.65e-05	0.000144	CcSEcCtD
Ezogabine—Nausea—Topiramate—epilepsy syndrome	1.56e-05	0.000136	CcSEcCtD
Ezogabine—KCNQ2—Developmental Biology—FGF2—epilepsy syndrome	7.97e-06	9.08e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—FGF2—epilepsy syndrome	7.97e-06	9.08e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Axon guidance—VEGFA—epilepsy syndrome	7.94e-06	9.04e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Axon guidance—VEGFA—epilepsy syndrome	7.94e-06	9.04e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—STXBP1—epilepsy syndrome	7.81e-06	8.9e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CYP2D6—epilepsy syndrome	7.78e-06	8.87e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CA4—epilepsy syndrome	7.78e-06	8.87e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—QDPR—epilepsy syndrome	7.78e-06	8.87e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CA4—epilepsy syndrome	7.78e-06	8.87e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—QDPR—epilepsy syndrome	7.78e-06	8.87e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Biological oxidations—POMC—epilepsy syndrome	7.76e-06	8.84e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Biological oxidations—POMC—epilepsy syndrome	7.76e-06	8.84e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—NT5E—epilepsy syndrome	7.61e-06	8.67e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALAD—epilepsy syndrome	7.61e-06	8.67e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TXNRD1—epilepsy syndrome	7.54e-06	8.59e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ADRA2A—epilepsy syndrome	7.41e-06	8.44e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—RELA—epilepsy syndrome	7.4e-06	8.43e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—RELA—epilepsy syndrome	7.4e-06	8.43e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—BCHE—epilepsy syndrome	7.38e-06	8.41e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AQP1—epilepsy syndrome	7.32e-06	8.34e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—COX3—epilepsy syndrome	7.32e-06	8.34e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—COX3—epilepsy syndrome	7.32e-06	8.34e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CACNA1A—epilepsy syndrome	7.26e-06	8.27e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALDH7A1—epilepsy syndrome	7.26e-06	8.27e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ST3GAL3—epilepsy syndrome	7.1e-06	8.1e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADK—epilepsy syndrome	7.06e-06	8.04e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PDXK—epilepsy syndrome	7.06e-06	8.04e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GLUD1—epilepsy syndrome	7.06e-06	8.04e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—FAR1—epilepsy syndrome	7.06e-06	8.04e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—L2HGDH—epilepsy syndrome	7.06e-06	8.04e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CERS1—epilepsy syndrome	7.06e-06	8.04e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—SLC2A1—epilepsy syndrome	7.04e-06	8.02e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PLCB1—epilepsy syndrome	6.96e-06	7.93e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADSL—epilepsy syndrome	6.96e-06	7.93e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—TH—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PFKL—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC6A8—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CACNA2D2—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—KCNB1—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLCO1A2—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC6A8—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PFKL—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLCO1A2—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—KCNB1—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CACNA2D2—epilepsy syndrome	6.94e-06	7.91e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GLUL—epilepsy syndrome	6.83e-06	7.78e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP2C19—epilepsy syndrome	6.78e-06	7.73e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—CYP11A1—epilepsy syndrome	6.74e-06	7.68e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CACNA1D—epilepsy syndrome	6.7e-06	7.63e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CHRM3—epilepsy syndrome	6.62e-06	7.54e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—KCNJ11—epilepsy syndrome	6.62e-06	7.54e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NHLRC1—epilepsy syndrome	6.45e-06	7.35e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—EPM2A—epilepsy syndrome	6.45e-06	7.35e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PNPO—epilepsy syndrome	6.45e-06	7.35e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GAMT—epilepsy syndrome	6.45e-06	7.35e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NEU1—epilepsy syndrome	6.35e-06	7.23e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NEU1—epilepsy syndrome	6.35e-06	7.23e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ATIC—epilepsy syndrome	6.35e-06	7.23e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—UPB1—epilepsy syndrome	6.35e-06	7.23e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—UPB1—epilepsy syndrome	6.35e-06	7.23e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ATIC—epilepsy syndrome	6.35e-06	7.23e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—MMP9—epilepsy syndrome	6.31e-06	7.19e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—MMP9—epilepsy syndrome	6.31e-06	7.19e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TXNRD1—epilepsy syndrome	6.27e-06	7.14e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HSD17B4—epilepsy syndrome	6.11e-06	6.96e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HSD17B4—epilepsy syndrome	6.11e-06	6.96e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AQP1—epilepsy syndrome	6.08e-06	6.93e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—QDPR—epilepsy syndrome	6e-06	6.84e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CA4—epilepsy syndrome	6e-06	6.84e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Biological oxidations—POMC—epilepsy syndrome	5.98e-06	6.82e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PPP1R3C—epilepsy syndrome	5.9e-06	6.72e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GBE1—epilepsy syndrome	5.9e-06	6.72e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GBE1—epilepsy syndrome	5.9e-06	6.72e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PPP1R3C—epilepsy syndrome	5.9e-06	6.72e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—SRC—epilepsy syndrome	5.82e-06	6.63e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—SRC—epilepsy syndrome	5.82e-06	6.63e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—HMOX1—epilepsy syndrome	5.79e-06	6.6e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—epilepsy syndrome	5.77e-06	6.57e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—CAT—epilepsy syndrome	5.71e-06	6.51e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—VEGFA—epilepsy syndrome	5.66e-06	6.45e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—VEGFA—epilepsy syndrome	5.66e-06	6.45e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—COX3—epilepsy syndrome	5.64e-06	6.43e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ABCB1—epilepsy syndrome	5.56e-06	6.33e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ASAH1—epilepsy syndrome	5.55e-06	6.32e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ASAH1—epilepsy syndrome	5.55e-06	6.32e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CHRM3—epilepsy syndrome	5.5e-06	6.27e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—KCNJ11—epilepsy syndrome	5.5e-06	6.27e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCG2—epilepsy syndrome	5.4e-06	6.15e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—STXBP1—epilepsy syndrome	5.4e-06	6.15e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—STXBP1—epilepsy syndrome	5.4e-06	6.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLCO1A2—epilepsy syndrome	5.35e-06	6.09e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC6A8—epilepsy syndrome	5.35e-06	6.09e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CACNA2D2—epilepsy syndrome	5.35e-06	6.09e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PFKL—epilepsy syndrome	5.35e-06	6.09e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—KCNB1—epilepsy syndrome	5.35e-06	6.09e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2C19—epilepsy syndrome	5.26e-06	5.99e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALAD—epilepsy syndrome	5.26e-06	5.99e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALAD—epilepsy syndrome	5.26e-06	5.99e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—NT5E—epilepsy syndrome	5.26e-06	5.99e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—NT5E—epilepsy syndrome	5.26e-06	5.99e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP11A1—epilepsy syndrome	5.23e-06	5.95e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—GPX1—epilepsy syndrome	5.17e-06	5.89e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALDH7A1—epilepsy syndrome	5.02e-06	5.72e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CACNA1A—epilepsy syndrome	5.02e-06	5.72e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALDH7A1—epilepsy syndrome	5.02e-06	5.72e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CACNA1A—epilepsy syndrome	5.02e-06	5.72e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ST3GAL3—epilepsy syndrome	4.91e-06	5.59e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ST3GAL3—epilepsy syndrome	4.91e-06	5.59e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—UPB1—epilepsy syndrome	4.89e-06	5.57e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ATIC—epilepsy syndrome	4.89e-06	5.57e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NEU1—epilepsy syndrome	4.89e-06	5.57e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—TNF—epilepsy syndrome	4.85e-06	5.53e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—TNF—epilepsy syndrome	4.85e-06	5.53e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADSL—epilepsy syndrome	4.81e-06	5.48e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADSL—epilepsy syndrome	4.81e-06	5.48e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CYP2D6—epilepsy syndrome	4.72e-06	5.37e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GLUL—epilepsy syndrome	4.72e-06	5.37e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GLUL—epilepsy syndrome	4.72e-06	5.37e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HSD17B4—epilepsy syndrome	4.71e-06	5.37e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CACNA1D—epilepsy syndrome	4.63e-06	5.27e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CACNA1D—epilepsy syndrome	4.63e-06	5.27e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PPP1R3C—epilepsy syndrome	4.55e-06	5.18e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GBE1—epilepsy syndrome	4.55e-06	5.18e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AGT—epilepsy syndrome	4.53e-06	5.16e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ADRA2A—epilepsy syndrome	4.49e-06	5.12e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCG2—epilepsy syndrome	4.49e-06	5.11e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—BCHE—epilepsy syndrome	4.47e-06	5.09e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—APOE—epilepsy syndrome	4.44e-06	5.06e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2C19—epilepsy syndrome	4.37e-06	4.98e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP11A1—epilepsy syndrome	4.34e-06	4.95e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TXNRD1—epilepsy syndrome	4.33e-06	4.93e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TXNRD1—epilepsy syndrome	4.33e-06	4.93e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ASAH1—epilepsy syndrome	4.28e-06	4.87e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—SLC2A1—epilepsy syndrome	4.27e-06	4.86e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PLCB1—epilepsy syndrome	4.22e-06	4.81e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—TH—epilepsy syndrome	4.2e-06	4.79e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AQP1—epilepsy syndrome	4.2e-06	4.79e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AQP1—epilepsy syndrome	4.2e-06	4.79e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—STXBP1—epilepsy syndrome	4.16e-06	4.74e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALAD—epilepsy syndrome	4.05e-06	4.62e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—NT5E—epilepsy syndrome	4.05e-06	4.62e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	4.04e-06	4.6e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CYP2D6—epilepsy syndrome	3.92e-06	4.47e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALDH7A1—epilepsy syndrome	3.87e-06	4.41e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CACNA1A—epilepsy syndrome	3.87e-06	4.41e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—POMC—epilepsy syndrome	3.81e-06	4.35e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—KCNJ11—epilepsy syndrome	3.8e-06	4.33e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CHRM3—epilepsy syndrome	3.8e-06	4.33e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—KCNJ11—epilepsy syndrome	3.8e-06	4.33e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CHRM3—epilepsy syndrome	3.8e-06	4.33e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ST3GAL3—epilepsy syndrome	3.78e-06	4.31e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ADRA2A—epilepsy syndrome	3.73e-06	4.25e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—BCHE—epilepsy syndrome	3.72e-06	4.23e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADSL—epilepsy syndrome	3.71e-06	4.22e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GLUL—epilepsy syndrome	3.64e-06	4.14e-05	CbGpPWpGaD
Ezogabine—KCNQ3—Developmental Biology—AKT1—epilepsy syndrome	3.61e-06	4.12e-05	CbGpPWpGaD
Ezogabine—KCNQ2—Developmental Biology—AKT1—epilepsy syndrome	3.61e-06	4.12e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CACNA1D—epilepsy syndrome	3.57e-06	4.07e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—SLC2A1—epilepsy syndrome	3.55e-06	4.04e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.54e-06	4.03e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—HMOX1—epilepsy syndrome	3.51e-06	4e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PLCB1—epilepsy syndrome	3.51e-06	4e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—TH—epilepsy syndrome	3.49e-06	3.98e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—ALB—epilepsy syndrome	3.48e-06	3.96e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.47e-06	3.95e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—CAT—epilepsy syndrome	3.46e-06	3.94e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ABCB1—epilepsy syndrome	3.37e-06	3.84e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TXNRD1—epilepsy syndrome	3.34e-06	3.8e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AQP1—epilepsy syndrome	3.24e-06	3.69e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—GPX1—epilepsy syndrome	3.13e-06	3.57e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCG2—epilepsy syndrome	3.1e-06	3.53e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCG2—epilepsy syndrome	3.1e-06	3.53e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—PTGS2—epilepsy syndrome	3.04e-06	3.47e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2C19—epilepsy syndrome	3.02e-06	3.44e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2C19—epilepsy syndrome	3.02e-06	3.44e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP11A1—epilepsy syndrome	3e-06	3.42e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP11A1—epilepsy syndrome	3e-06	3.42e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.98e-06	3.4e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CHRM3—epilepsy syndrome	2.93e-06	3.34e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—KCNJ11—epilepsy syndrome	2.93e-06	3.34e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—HMOX1—epilepsy syndrome	2.92e-06	3.32e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—CAT—epilepsy syndrome	2.88e-06	3.28e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ABCB1—epilepsy syndrome	2.8e-06	3.19e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AGT—epilepsy syndrome	2.75e-06	3.13e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.72e-06	3.1e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CYP2D6—epilepsy syndrome	2.71e-06	3.09e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CYP2D6—epilepsy syndrome	2.71e-06	3.09e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—APOE—epilepsy syndrome	2.69e-06	3.06e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—GPX1—epilepsy syndrome	2.6e-06	2.97e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ADRA2A—epilepsy syndrome	2.58e-06	2.94e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ADRA2A—epilepsy syndrome	2.58e-06	2.94e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—BCHE—epilepsy syndrome	2.57e-06	2.93e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—BCHE—epilepsy syndrome	2.57e-06	2.93e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—SLC2A1—epilepsy syndrome	2.45e-06	2.79e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—SLC2A1—epilepsy syndrome	2.45e-06	2.79e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PLCB1—epilepsy syndrome	2.42e-06	2.76e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PLCB1—epilepsy syndrome	2.42e-06	2.76e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—TH—epilepsy syndrome	2.41e-06	2.75e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—TH—epilepsy syndrome	2.41e-06	2.75e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCG2—epilepsy syndrome	2.39e-06	2.72e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.38e-06	2.71e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2C19—epilepsy syndrome	2.33e-06	2.65e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP11A1—epilepsy syndrome	2.31e-06	2.64e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—POMC—epilepsy syndrome	2.31e-06	2.63e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AGT—epilepsy syndrome	2.28e-06	2.6e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—APOE—epilepsy syndrome	2.24e-06	2.55e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—ALB—epilepsy syndrome	2.11e-06	2.4e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CYP2D6—epilepsy syndrome	2.09e-06	2.38e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—HMOX1—epilepsy syndrome	2.01e-06	2.3e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	2.01e-06	2.3e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—CAT—epilepsy syndrome	1.99e-06	2.27e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—CAT—epilepsy syndrome	1.99e-06	2.27e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ADRA2A—epilepsy syndrome	1.99e-06	2.26e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—BCHE—epilepsy syndrome	1.98e-06	2.26e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	1.93e-06	2.2e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ABCB1—epilepsy syndrome	1.93e-06	2.2e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—POMC—epilepsy syndrome	1.92e-06	2.19e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—SLC2A1—epilepsy syndrome	1.89e-06	2.15e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PLCB1—epilepsy syndrome	1.87e-06	2.13e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—TH—epilepsy syndrome	1.86e-06	2.12e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—PTGS2—epilepsy syndrome	1.84e-06	2.1e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—GPX1—epilepsy syndrome	1.8e-06	2.05e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—GPX1—epilepsy syndrome	1.8e-06	2.05e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—ALB—epilepsy syndrome	1.75e-06	2e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AGT—epilepsy syndrome	1.58e-06	1.8e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AGT—epilepsy syndrome	1.58e-06	1.8e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—HMOX1—epilepsy syndrome	1.55e-06	1.77e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—APOE—epilepsy syndrome	1.54e-06	1.76e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—APOE—epilepsy syndrome	1.54e-06	1.76e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—CAT—epilepsy syndrome	1.53e-06	1.75e-05	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—PTGS2—epilepsy syndrome	1.53e-06	1.75e-05	CbGpPWpGaD
Ezogabine—NAT2—Metabolism—AKT1—epilepsy syndrome	1.53e-06	1.74e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ABCB1—epilepsy syndrome	1.49e-06	1.7e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—GPX1—epilepsy syndrome	1.39e-06	1.58e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—POMC—epilepsy syndrome	1.33e-06	1.51e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—POMC—epilepsy syndrome	1.33e-06	1.51e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AGT—epilepsy syndrome	1.22e-06	1.38e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.38e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—ALB—epilepsy syndrome	1.21e-06	1.38e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—APOE—epilepsy syndrome	1.19e-06	1.36e-05	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.21e-05	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.21e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—POMC—epilepsy syndrome	1.02e-06	1.17e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—ALB—epilepsy syndrome	9.33e-07	1.06e-05	CbGpPWpGaD
Ezogabine—UGT1A4—Metabolism—AKT1—epilepsy syndrome	9.26e-07	1.06e-05	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—PTGS2—epilepsy syndrome	8.16e-07	9.3e-06	CbGpPWpGaD
Ezogabine—UGT1A3—Metabolism—AKT1—epilepsy syndrome	7.7e-07	8.77e-06	CbGpPWpGaD
Ezogabine—UGT1A1—Metabolism—AKT1—epilepsy syndrome	5.32e-07	6.06e-06	CbGpPWpGaD
Ezogabine—UGT1A9—Metabolism—AKT1—epilepsy syndrome	5.32e-07	6.06e-06	CbGpPWpGaD
Ezogabine—CYP2A6—Metabolism—AKT1—epilepsy syndrome	4.1e-07	4.67e-06	CbGpPWpGaD
